3Y Annualised Return
▼-33.85%
Global Longlife Hospital and Research Stock Performance
|
|
|
Global Longlife Hospital and Research Company background
Founded in: 2012
Managing director: Dhruv Sureshkumar Jani
Global Longlife Hospital and Research Limited was originally incorporated as Global Longlife Hospital and Research Private Limited on January 20, 2012 with Registrar of Companies, Gujarat. Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to Global Longlife Hospital and Research Limited vide fresh Certificate of Incorporation dated August 31, 2021.The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012. The Hospital started journey in 2015 determined to build an institution that offer to every human being, high quality healthcare at affordable prices in Ahmedabad. Mr. Dhruv Jani had also joined the hospital business with his father in July 2015. The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017. At present the Promoters along with his family members hold 81.43 % stake in the Company.The Company came up with an Initial Public Offer by 35,00,000 Equity Shares of Rs. 10/ each, aggregating to Rs. 49 Crore in April, 2022.The Company is a Multi Speciality Tertiary Care Hospital of Gujarat with 110 beds well equipped for Medical Surgical Specialities. Company provide platform to the doctors for treatment of their patients. Apart from the 11 full time consultants, the Hospital has a team of more than 30 experienced doctors as a consultant to serve patients. Its staff strength comprises 37 nursing staff and more than 50 paramedical, corporate and support staff and pharmacists. The Hospital provide comprehensive healthcare services across a range of specialties and superspecialties. These include Cardiology, Allergy and immunology, oncology, Diabetes Endocrinology, Anesthesiology, Pain Management, Internal Medicine , Nephrology, Neurology, Dermatology, plastic Surgery and others.
As of 29 Aug, 2025, Global Longlife Hospital and Research share price is ₹25.2. The stock opened at ₹24 and had closed at ₹24 the previous day. During today’s trading session, Global Longlife Hospital and Research share price moved between ₹23.96 and ₹25.15, with an average price for the day of ₹24.55. Over the last 52 weeks, the stock has recorded a low of ₹18.30 and a high of ₹46.44. In terms of performance, Global Longlife Hospital and Research share price has declined by 5% over the past six months and has declined by 28.24% over the last year.
Global Longlife Hospital and Research SIP Return Calculator
Over the past
3 years
Total Investment of ₹1,95,00,000
Would have become ₹1,22,35,508 (-37.25%)
Daily SIP of ₹25,000 would have become ₹1,22,35,508 in 3 years with a gain of ₹-72,64,491 (-37.25%)
Global Longlife Hospital and Research Fundamental
Market Cap (in crs)
26.41
Face Value
10
Turnover (in lacs)
1.76
Key Metrics
Qtr Change %
45.84% Fall from 52W High
-18.3
Dividend yield 1yr %
0
Global Longlife Hospital and Research Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
25.15
Current Price
5Day EMA
23.90
10Day EMA
23.50
12Day EMA
23.40
20Day EMA
23.60
26Day EMA
23.80
50Day EMA
24.60
100Day EMA
25.90
200Day EMA
29.10
5Day SMA
23.80
10Day SMA
23.00
20Day SMA
23.40
30Day SMA
23.80
50Day SMA
26.00
100Day SMA
24.90
150Day SMA
27.20
200Day SMA
29.00
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 7000 Rs | 7000 Rs |
Week Rs | 4500 Rs | 4500 Rs |
Month Rs | null Rs | null Rs |
Resistance & Support
24.75
Pivot
Resistance
First Resistance
25.55
Second Resistance
25.94
Third Resistance
26.74
Support
First Support
24.36
Second support
23.56
Third Support
23.17
Relative Strength Index
55.23
Money Flow Index
18.97
MACD
-0.41
MACD Signal
-0.74
Average True Range
1.20
Average Directional Index
13.53
Rate of Change (21)
0.60
Rate of Change (125)
-21.41
Global Longlife Hospital and Research Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
38.00 | 28.39 | 28.34 | 59.9 | 37.75 | 4.91% | 14.98% | 11.76% | 1.96% | 68.89% | 0.00% | 0.00 | 90.10 | -15.02 | |
21.00 | 8.61 | 16.47 | 25.2 | 20.30 | -6.25% | -1.18% | -2.19% | -15.90% | 57.89% | 0.00% | 21.00 | 90.10 | 0.85 | |
85.02 | 36.26 | 28.21 | 85.44 | 83.36 | 14.67% | 49.05% | 148.96% | 164.78% | 286.45% | 0.00% | 93.43 | 90.10 | 28.00 | |
Nidan Laboratories And Healthcare Ltd. | - | 18.10 | - | - | - | - | - | - | - | - | - | - | - | - |
47.00 | 32.00 | 31.6 | 54.95 | 41.00 | 14.63% | 9.30% | 11.90% | -7.83% | 0.00% | 0.00% | 0.00 | 90.10 | 2.39 | |
25.40 | 15.42 | 16.01 | 42.67 | 25.40 | 0.00% | 10.92% | 2.63% | -43.44% | 0.00% | 0.00% | 28.86 | 90.10 | 1.65 |
Global Longlife Hospital and Research Share Price FAQs
How to buy Global Longlife Hospital and Research shares?
You can easily buy Global Longlife Hospital and Research shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Global Longlife Hospital and Research ?
The 52-week high and low of Global Longlife Hospital and Research share price is ₹46.44 and ₹18.3 as of 29/8/2025.
Please be aware that Global Longlife Hospital and Research stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account